Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry J M Groen

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Plos One|December 8, 2017
Resource utilization in lung cancer diagnostic procedures: Current use and budget consequencesSander Brinkhof, Harry J M Groen, Sabine S Siesling, et al.
Anticancer Research|July 28, 2004
Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatmentFloris M Wachters, Winette T A Van Der Graaf, Harry J M Groen
Lung Cancer (Amsterdam, Netherlands)|March 28, 2006
Third-line chemotherapy for small cell lung cancerWouter K de Jong, Nick H T ten Hacken, Harry J M Groen
Annals of Translational Medicine|March 28, 2015
The value of proteomics in lung cancerAnthonie J van der Wekken, Thijo J N Hiltermann, Harry J M Groen
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2015
Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLCLiseth L van den Berg, Theo J Klinkenberg, Harry J M Groen, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2004
Phase II study of docetaxel and carboplatin as second-line treatment in NSCLCFloris M Wachters, John W G van Putten, H Marike Boezen, et al.
Anticancer Research|April 1, 2009
Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancerWouter K De Jong, Gonda F Verpooten, Henk Kramer, et al.
Cancer|June 6, 2006
Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspirationHenk Kramer, Joyce Sanders, Wendy J Post, et al.
Cancer Treatment Reviews|May 8, 2012
Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapyVikram Rao Bollineni, Erwin M Wiegman, Jan Pruim, et al.
Biochemical Pharmacology|July 3, 2002
JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatinEelco Fokkema, Harry J M Groen, Marco N Helder, et al.
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Plos One|December 8, 2017
Resource utilization in lung cancer diagnostic procedures: Current use and budget consequencesSander Brinkhof, Harry J M Groen, Sabine S Siesling, et al.
Anticancer Research|July 28, 2004
Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatmentFloris M Wachters, Winette T A Van Der Graaf, Harry J M Groen
Lung Cancer (Amsterdam, Netherlands)|March 28, 2006
Third-line chemotherapy for small cell lung cancerWouter K de Jong, Nick H T ten Hacken, Harry J M Groen
Annals of Translational Medicine|March 28, 2015
The value of proteomics in lung cancerAnthonie J van der Wekken, Thijo J N Hiltermann, Harry J M Groen
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2015
Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLCLiseth L van den Berg, Theo J Klinkenberg, Harry J M Groen, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2004
Phase II study of docetaxel and carboplatin as second-line treatment in NSCLCFloris M Wachters, John W G van Putten, H Marike Boezen, et al.
Anticancer Research|April 1, 2009
Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancerWouter K De Jong, Gonda F Verpooten, Henk Kramer, et al.
Cancer|June 6, 2006
Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspirationHenk Kramer, Joyce Sanders, Wendy J Post, et al.
Cancer Treatment Reviews|May 8, 2012
Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapyVikram Rao Bollineni, Erwin M Wiegman, Jan Pruim, et al.
Biochemical Pharmacology|July 3, 2002
JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatinEelco Fokkema, Harry J M Groen, Marco N Helder, et al.
Pageof 28